SS 02 - GI 1: The OPERATIC side of Rectal Cancer - Organ Preservation, Evaluating Recurrences, And The Immune Checkpoints

Presentations

• 03:40pm - 03:50pm PT

  Radiotherapy followed by CAPOX and Tislelizumab in MSS Locally Advanced Rectal Cancer with Resectable Metastases: Results of the MIRACLE-1 Study

  Speaker: Zhen Zhang, MD, PhD - Fudan University Shanghai Cancer Center, shanghai
• 02:30pm - 03:45pm PT

  GI 1: The OPERATIC side of Rectal Cancer - Organ Preservation, Evaluating Recurrences, And The Immune Checkpoints

  Speaker: Jacob Miller, MD - Cleveland Clinic Taussig Cancer Institute, Cleveland
• 02:30pm - 03:45pm PT

  GI 1: The OPERATIC side of Rectal Cancer - Organ Preservation, Evaluating Recurrences, And The Immune Checkpoints

  Speaker: Alexandra Hotca-Cho, MD - University of California San Francisco, San Francisco
• 02:30pm - 02:40pm PT

  Quality of Life and 5-Year Long-Term Organ Preservation in Early Rectal Adenocarcinoma Final Results from the OPERA Trial

  Speaker: Syrine ben Dhia, MD - Antoine lacassagne center, nice
• 02:40pm - 02:50pm PT

  Evaluating Short Course Radiation and ctDNA for Organ Preservation: The Nonoperative Management and Early Response Assessment in Rectal Cancer (NOM-ERA) Trial

  Speaker: Hyun Kim, MD - Washington University School of Medicine, St. Louis
• 02:50pm - 03:00pm PT

  Comparison of Patterns of Locoregional Recurrence in Total Neoadjuvant Therapy vs. Chemoradiotherapy for Locally Advanced Rectal Cancer in the STELLAR Study

  Speaker: Jiacheng Shuai, MD - State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science, Beijing
• 03:00pm - 03:10pm PT

  IMPARC: A Prospective Trial of Stereotactic Proton Reirradiation for Locoregionally Recurrent Rectal Cancer

  Speaker: Poonam Dalwadi, MD, BS - Washington University/B-JH/SLCH Consortium, St. Louis
• 03:10pm - 03:20pm PT

  Perioperative Chemotherapy Duration Affects the Survival of Locally Advanced Rectal Cancer: A Post-Hoc Analysis of a Multicenter Randomized, Phase III Trial

  Speaker: Tongzhen Xu, MD - Chinese Academy of Medical Science, Bejing
• 03:20pm - 03:30pm PT

  Efficacy and Safety of Short-Course Radiotherapy Followed By Sequential Chemotherapy and AK104 in Locally Advanced Rectal Cancer: Results from a Prospective, Multicenter Phase II Trial

  Speaker: Tongzhen Xu, MD - Chinese Academy of Medical Science, Bejing
• 03:30pm - 03:40pm PT

  Discussant

  Speaker: Jeffrey Olsen, MD - University of Colorado School of Medicine, Aurora